@article{728c6ab6ae1a443a8d0a6df888dbe9c8,
title = "Transforming ovarian cancer care by targeting minimal residual disease",
abstract = "Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.",
author = "Jazaeri, {Amir A.} and Rachel Grisham and Anne Knisely and Stefani Spranger and Dmitriy Zamarin and Hillman, {R. Tyler} and Lawson, {Barrett C.} and Burns, {Kathleen H.} and Sanghoon Lee and Westin, {Shannon N.} and Enrico Moiso and Williams, {Marc J.} and Bardhan, {Neelkanth M.} and Thomas Pisanic and Ursula Matulonis and Britta Weigelt and Shih, {Ie Ming} and Konstantinopoulos, {Panagiotis A.} and Stephanie Gaillard and Linghua Wang and Carol Aghajanian and D'Andrea, {Alan D.} and Paula Hammond and Sohrab Shah and Wucherpfennig, {Kai W.} and Lu, {Karen H.}",
note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",
year = "2023",
month = nov,
day = "10",
doi = "10.1016/j.medj.2023.08.004",
language = "English (US)",
volume = "4",
pages = "755--760",
journal = "Med",
issn = "2666-6359",
publisher = "Cell Press",
number = "11",
}